Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single‐Center Phase I Open‐Label Trial

Despite advances in early diagnosis and behavioral therapies, more effective treatments for children with autism spectrum disorder (ASD) are needed. We hypothesized that umbilical cord blood‐derived cell therapies may have potential in alleviating ASD symptoms by modulating inflammatory processes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawson, Geraldine, Sun, Jessica M., Davlantis, Katherine S., Murias, Michael, Franz, Lauren, Troy, Jesse, Simmons, Ryan, Sabatos‐DeVito, Maura, Durham, Rebecca, Kurtzberg, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442708/
https://www.ncbi.nlm.nih.gov/pubmed/28378499
http://dx.doi.org/10.1002/sctm.16-0474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442708/
https://www.ncbi.nlm.nih.gov/pubmed/28378499
http://dx.doi.org/10.1002/sctm.16-0474

Ejemplares similares